FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077896 [Registered on: 10/12/2024] Trial Registered Prospectively
Last Modified On: 09/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Interventional]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of trivruttyadi malahara in post operative fistulectomy wound in comparison of placentrex gel  
Scientific Title of Study   Effect Of Trivruttyadi Malahara And Placentrex Gel On Granulation Formation (Utsadana) In The Management Of Post Operative Fistulectomy Wound : A Randomized Controlled Trial 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shubhangi Somnath Birdawade 
Designation  PG Scholar 
Affiliation  Shri Ayurved Mahavidyalaya,Nagpur 
Address  Opd No.7,Shalyatantra Department, Pakwasa Samanvay Rugnalaya,Shri Ayurved Mahavidyalaya,Hanuman Nagar Nagpur ,Dhanwantari Marga,Nagpur Maharashtra 440024 Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9130054126  
Fax    
Email  shubhangibirdawade6@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jyoti Pradeep Dalal 
Designation  HOD And Professor Of Shalya Tantra 
Affiliation  Shri Ayurved Mahavidyalaya,Nagpur 
Address  Opd No.7,Shalyatantra Department, Pakwasa Samanvay Rugnalaya,Shri Ayurved Mahavidyalaya,Hanuman Nagar Nagpur ,Dhanwantari Marga,Nagpur Maharashtra 440024 Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9975830051  
Fax    
Email  drjyoti.dalal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shubhangi Somnath Birdawade 
Designation  PG Scholar 
Affiliation  Shri Ayurved Mahavidyalaya,Nagpur 
Address  Opd No.7,Shalyatantra Department, Pakwasa Samanvay Rugnalaya,Shri Ayurved Mahavidyalaya,Hanuman Nagar Nagpur ,Dhanwantari Marga,Nagpur Maharashtra 440024 Nagpur

Nagpur
MAHARASHTRA
440024
India 
Phone  9130054126  
Fax    
Email  shubhangibirdawade6@gmail.com  
 
Source of Monetary or Material Support  
Shalyatantra department,Pakwasa samanway rugnalaya,Shri Ayurved Mahavidyalaya, Hanuman nagar, Nagpur, 440024 
 
Primary Sponsor  
Name  Shri Ayurved Mahavidyalaya,Nagpur 
Address  Pakwasa Samanway Rugnalaya,Hanuman Nagar,Dhanwantari Marga,Nagpur 440024 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrShubhangi Somnath Birdawade  Shri Ayurved Mahavidyalaya,Nagpur  Opd No.7 Shalyatantra Department ,Pakwasa Samanway Rugnalaya, Shri Ayurved Mahavidyalaya,Hanuman Nagar,Dhanwantari Marga , Nagpur,Maharashtra 440024
Nagpur
MAHARASHTRA 
9130054126

shubhangibirdawade6@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC of Shri Ayurved Mahavidyalaya  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L99||Other disorders of skin and subcutaneous tissue in diseases classified elsewhere. Ayurveda Condition: BAGANDARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Placentrex gelPlacenta extract belongs to the group of medicine called human derived ingredients.It works by increasing blood flow and level of certain proteins .This promotes tissue regeneration.
2Intervention ArmDrugClassical(1) Medicine Name: Trivruttyadi malahara, Reference: Su.chi 8/40, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 5(g), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1)Patients with post operative fistulectomy wound
(Low anal single tract fistula with tract length less than or equal to 6 cm)
2)The patients from the age group 18 to 50 years irrespective of gender, religion, occupation, education, and socio- economic status. 
 
ExclusionCriteria 
Details  1)Patients having uncontrolled Diabetes Mellitus and Hypertension

2) Patient with Secondary fistula in ano. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Evalutaion of efffect of Trivruttyadi Malahara in management of post- operative fistulectomy wound healing.  At the end of 21 days  
 
Secondary Outcome  
Outcome  TimePoints 
Trivruttyadi Malahara is more effective than Placentrex gel   At the end of 21 days  
 
Target Sample Size   Total Sample Size="76"
Sample Size from India="76" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   21/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    This study will be carried out at opd of shalyatantra of Pakwasa Samanvay Rugnalaya, Nagpur .This is an open label randomized controlled trial aims at studying the comparison between Trivruttyadi malahara and placentrex gel in the management of post operative fistulectomy wound with special reference of granulation formation. Total 76 patients will be included and will be randomly divided into two groups i.e. Group A and Group B each containing 38 patients. Group A will be trial group where patients will receive application of Trivruttyadi Malahara and Group B will be control group will receive application of Placentrex Gel. Then patients will be observed on 7th, 14th and 21st day All the findings will be recorded in case record form, At the end of trial, collected data will be analyzed and result will be drawn accordingly. 
Close